AUTL - Autolus Therapeutics Ltd - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AUTL is currently covered by 2 analysts with an average price target of $7.5. This is a potential upside of $7.85 (406.76%) from yesterday's end of day stock price of $1.48.

Autolus Therapeutics Ltd's activity chart (see below) currently has 51 price targets and 56 ratings on display. The stock rating distribution of AUTL is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.81% with an average time for these price targets to be met of 55.92 days.

Highest price target for AUTL is $10, Lowest price target is $5, average price target is $7.5.

Most recent stock forecast was given by from NEEDHAM on 09-Apr-2026. First documented stock forecast 12-Aug-2019.

Currently out of the existing stock ratings of AUTL, 9 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Mar-2022

$10

$8.39 (521.12%)

$10

3 months 5 days ago
(09-Apr-2026)

7/27 (25.93%)

$8.53 (580.27%)

225

Buy Since 27-Mar-2023

$5

$3.39 (210.56%)

$6

11 months 1 days ago
(13-Aug-2025)

0/6 (0%)

$3.16 (171.74%)

Buy Since 22-Jul-2020

$10

1 years 3 months 13 days ago
(01-Apr-2025)

0/8 (0%)

$8.45 (545.16%)

Hold Since 09-Nov-2021

$7.6

$5.99 (372.05%)

1 years 7 months 26 days ago
(18-Nov-2024)

1/2 (50%)

$4.61 (154.18%)

9

Hold Since 07-Mar-2023

$5

$3.51 (235.57%)

$6

3 years 2 months 9 days ago
(05-May-2023)

2/3 (66.67%)

$3.11 (164.55%)

259

Show more analysts

Please expand the browser size to see the chart

What is AUTL (Autolus Therapeutics Ltd) average time for price targets to be met?

On average it took 55.92 days on average for the stock forecasts to be realized with a an average price target met ratio 16.81

Which analyst has the current highest performing score on AUTL (Autolus Therapeutics Ltd) with a proven track record?

GIL BLUM

Which analyst has the most public recommendations on AUTL (Autolus Therapeutics Ltd)?

Gil Blum works at NEEDHAM and has 34 price targets and 39 ratings on AUTL

Which analyst is the currently most bullish on AUTL (Autolus Therapeutics Ltd)?

Debjit Chattopadhyay with highest potential upside - $22.51

Which analyst is the currently most reserved on AUTL (Autolus Therapeutics Ltd)?

Asthika Goonewardene with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?